THERAPEUTIC REGIMENS USED, PATIENT PROFILE

THE CLIENT’S BUSINESS OBJECTIVE:
Provide all interested market participants (PEX syndication project) with detailed information on:
– proportion of patients with the condition (by subtype) in whom molecular, immunohistochemical diagnosis is performed;
– molecular, immunohistochemical tests performed;
– result of the research carried out;
– therapies used in a selected group of patients covered by a drug programme;
– clinical profile characterising the selected patient group.

PEX SOLUTION
– PEX syndicated study using a retrospective patient history methodology

DATA SOURCE
– patient records, 600 descriptions;
– Retrospective analysis of patient histories, 265 descriptions;
– interview with a doctor (online/CAWI), 20 specialists.

PROJECT RESULT
A detailed description of the market situation with regard to the diagnosis and treatment of specific patient groups, taking into account the breakdowns into different subtypes.
Each project learner was in a different market situation – planned product launch/established position in a drug programme. The data collected provided key knowledge for each in planning product support activities.